Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13370047 | 0.65 | — | — | |
| SCHEMBL27835768 | 0.64 | — | — | |
| SCHEMBL22292613 | 0.64 | GAA (0.31) | — | |
| SCHEMBL27795108 | 0.64 | — | — | |
| SCHEMBL7178297 | 0.64 | LMNA (0.31) | — | |
| SCHEMBL18727733 | 0.61 | — | — | |
| SCHEMBL7360580 | 0.61 | — | — | |
| SCHEMBL20630387 | 0.61 | — | — | |
| SCHEMBL24619980 | 0.60 | KDM4E (0.33) | ALDH1A1 | |
| SCHEMBL24916721 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101594868-B | Pharmaceutical composition with antipsychotic, antidepressant or antiepileptic activity and reduced side effects | GENE RES LAB INC US N | 2012-12-12 | — | — | CN | disclosed |
| CN-101636391-B | Novel prophylactic and/or therapeutic agent for neurogenic pain | ASTELLAS PHARMA INC JP | 2012-11-28 | — | — | CN | disclosed |
| CN-101657211-A | Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity | AETERNA ZENTARIS GMBH DE | 2010-02-24 | — | — | CN | disclosed |
| CN-101636391-A | Novel prophylactic and/or therapeutic agent for neurogenic pain | ASTELLAS PHARMA INC | 2010-01-27 | — | — | CN | disclosed |
| CN-101594868-A | Pharmaceutical composition with antipsychotic, antidepressant or antiepileptic activity and reduced side effects | N GENE RES LAB INC (US) | 2009-12-02 | — | — | CN | disclosed |